Skip to main content
. 2011 Apr 28;6(4):e19146. doi: 10.1371/journal.pone.0019146

Table 4. Fasting plasma lipids by genotype for three SNPs of FFAR1.

rs2301151 rs1573611 rs16970264
Difference P Difference P Difference P
AA GA GG TT TC CC AA GA GG
Total Cholesterol (mmol/L)
mean 5.57 5.77 6.14 0.2 0.01 5.62 5.59 5.71 0.08 0.33 5.67 5.39 5.72 0.3 0.02
SE 0.06 0.07 0.25 0.20 0.01 0.06 0.68 0.14 0.05
n 233 155 16 20 137 247 3 47 349
LDL Cholesterol (mmol/L)
mean 3.51 3.62 3.9 0.13 0.09 3.59 3.5 3.6 0.05 0.50 4.02 3.31 3.61 0.23 0.05
SE 0.06 0.07 0.22 0.19 0.08 0.05 0.63 0.13 0.05
n 233 155 16 20 138 247 3 47 350
HDL Cholesterol (mmol/L)
mean 1.41 1.44 1.60 0.04 0.16 1.40 1.40 1.45 0.04 0.17 1.15 1.36 1.44 0.09 0.05
SE 0.02 0.03 0.08 0.08 0.03 0.02 0.10 0.05 0.02
n 233 155 16 20 137 247 3 47 349
Triglycerides (mmol/L)
Geometric mean 1.27 1.35 1.34 1.04 0.35 1.23 1.32 1.30 0.99 0.75 1.10 1.42 1.29 0.95 0.49
95% CI [1.20, 1.36] [1.25, 1.46] [1.13, 1.59] [0.98, 1.55] [1.23, 1.43] [1.22, 1.39 [0.71, 1.69] [1.21, 1.67] [1.22, 1.35]
n 233 154 16 20 137 246 3 46 349
Non-esterified fatty acids (µmol/L)
Geometric mean 651 650 522 0.94 0.04 630 648 646 0.99 0.63 603 635 650 1.04 0.5
95% CI [622, 681] [610, 693] [397, 689] [528, 752] [611, 687] [614, 679] [151, 2403] [563, 716] [624, 676]
n 226 149 16 20 132 240 3 46 337
Total: HDL cholesterol ratio
mean 4.14 4.25 3.98 0.05 0.60 4.22 4.24 4.15 −0.08 0.36 4.94 4.14 4.17 −0.02 0.91
SE 0.07 0.09 0.23 0.23 0.10 0.07 0.41 0.16 0.06
n 233 155 16 20 137 247 3 47 349

Data are presented as mean, SEM, n (Total, LDL, HDL and total: HDL cholesterol) or geometric mean, 95% confidence intervals, n (triglycerides, non-esterified fatty acids) stratified by genotype for each of the three SNPs. For each genotype the risk allele was defined as the BMI-increasing allele except for rs16970264 where the risk allele was defined according to the total-cholesterol increasing effect and the data are presented as the additive model. The differences in trait by genotype were assessed by linear regression analysis coding the number of risk alleles as 0,1,2. Data for plasma NEFA and triglycerides were logged for regression analysis. The beta-coefficient from the regression was exponentiated which approximates to the percentage difference. The P-value for the regression is presented. No associations reached statistical significance by the FDR-controlling procedure q* = 0.05. The recessive and dominant models, defined according to the risk allele are presented in Supplementary Table S3.